AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Clinical trial NCT00241605 · COMPLETED

Trial details

NCT number: NCT00241605
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2003-06-25
Primary completion: 2005-12-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.